{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T17:04:57Z","timestamp":1794416697170,"version":"4.9.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.xkme.2023.100705","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T12:27:30Z","timestamp":1695817650000},"page":"100705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder"],"prefix":"10.1016","volume":"5","author":[{"given":"Rahul N.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2023.100705_bib1","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/634903","article-title":"Cardiorenal syndrome caused by heart failure with preserved ejection fraction","volume":"2011","author":"Lazzeri","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.xkme.2023.100705_bib2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.CIR.0000048123.22359.A0","article-title":"Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations","volume":"107","author":"Kawaguchi","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.xkme.2023.100705_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","article-title":"Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction","volume":"15","author":"Abudiab","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"10.1016\/j.xkme.2023.100705_bib4","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.xkme.2023.100705_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100705_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A\u00a0simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3904\/kjim.2021.272","article-title":"HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction","volume":"37","author":"Egashira","year":"2022","journal-title":"Korean J Intern Med"},{"issue":"3","key":"10.1016\/j.xkme.2023.100705_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2005.08.051","article-title":"Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study","volume":"47","author":"Anwaruddin","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100705_bib10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.xkme.2023.100705_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"issue":"9888","key":"10.1016\/j.xkme.2023.100705_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.xkme.2023.100705_bib13","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome","volume":"2018","author":"Mihai","year":"2018","journal-title":"J\u00a0Immunol Res"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.116.07418","article-title":"Vascular mineralocorticoid receptors: linking risk factors, hypertension, and heart disease","volume":"68","author":"Lother","year":"2016","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.xkme.2023.100705_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.xkme.2023.100705_bib16","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/ajh\/hpy120","article-title":"Mineralocorticoid receptor and cardiovascular disease","volume":"31","author":"Buonafine","year":"2018","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.xkme.2023.100705_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1681\/ASN.2020071041","article-title":"The mineralocorticoid receptor in salt-sensitive hypertension and renal injury","volume":"32","author":"Ayuzawa","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100705_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2008.152","article-title":"Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients","volume":"21","author":"Henschkowski","year":"2008","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/HYPERTENSIONAHA.121.17263","article-title":"Activation of Rac1-mineralocorticoid receptor pathway contributes to renal injury in salt-loaded db\/db mice","volume":"78","author":"Hirohama","year":"2021","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.xkme.2023.100705_bib20","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.bbadis.2016.10.025","article-title":"Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction","volume":"1863","author":"Jia","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.kisu.2021.11.006","article-title":"The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis","volume":"12","author":"Luther","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"issue":"6","key":"10.1016\/j.xkme.2023.100705_bib22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cell.2014.05.012","article-title":"Increased adipocyte O2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity","volume":"157","author":"Lee","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.xkme.2023.100705_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1681\/ASN.2019070677","article-title":"Mechanisms of metabolic acidosis-induced kidney injury in chronic kidney disease","volume":"31","author":"Wesson","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061991","article-title":"Acidosis activation of the proton-sensing GPR4 receptor stimulates vascular endothelial cell inflammatory responses revealed by transcriptome analysis","volume":"8","author":"Dong","year":"2013","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib25","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00359.2016","article-title":"Ironing out the cross talk between FGF23 and inflammation","volume":"312","author":"David","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2023.100705_bib27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/cvr\/cvy316","article-title":"The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification","volume":"115","author":"Carracedo","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"21","key":"10.1016\/j.xkme.2023.100705_bib28","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of interleukin-1beta by canakinumab and cardiovascular outcomes in patients with chronic kidney disease","volume":"71","author":"Ridker","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/toxins12040227","article-title":"Inflammation and premature ageing in chronic kidney disease","volume":"12","author":"Ebert","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cells9010242","article-title":"Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding","volume":"9","author":"Simmonds","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.xkme.2023.100705_bib32","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/CIRCULATIONAHA.109.860171","article-title":"Cardiac titin: a multifunctional giant","volume":"121","author":"LeWinter","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.xkme.2023.100705_bib33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.xkme.2023.100705_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/toxins12030185","article-title":"Klotho\/FGF23 and Wnt signaling as important players in the comorbidities associated with chronic kidney disease","volume":"12","author":"Munoz-Castaneda","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.xkme.2023.100705_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2019.08.040","article-title":"Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction","volume":"296","author":"Vergaro","year":"2019","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.xkme.2023.100705_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117332","article-title":"A\u00a0systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction","volume":"10","author":"Verloop","year":"2015","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.xkme.2023.100705_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.HYP.0000145180.38707.84","article-title":"Pathophysiology of hypertensive renal damage: implications for therapy","volume":"44","author":"Bidani","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.xkme.2023.100705_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11897-015-0254-8","article-title":"Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?","volume":"12","author":"Colombo","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.xkme.2023.100705_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5414\/CN111090","article-title":"Diuretic resistance in acute decompensated HFpEF vs. HFrEF","volume":"100","author":"Sharma","year":"2023","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100705_bib41","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor","volume":"71","author":"van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ejhf.2393","article-title":"Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BioStat-CHF study","volume":"24","author":"Alnuwaysir","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.xkme.2023.100705_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00392-018-1344-x","article-title":"Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life","volume":"108","author":"Bekfani","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib44","first-page":"1199","article-title":"Iron deficiency: impact on functional capacity and quality of life in heart failure with preserved ejection fraction","volume":"9","author":"Alcaide-Aldeano","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.xkme.2023.100705_bib45","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/ehf2.12797","article-title":"Anaemia, iron deficiency and heart failure in 2020: facts and numbers","volume":"7","author":"Chopra","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.xkme.2023.100705_bib46","first-page":"11","article-title":"Iron deficiency in heart failure: mechanisms and pathophysiology","author":"Alnuwaysir","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.xkme.2023.100705_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.xkme.2023.100705_bib48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.445","article-title":"Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction","volume":"18","author":"Unger","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"48","key":"10.1016\/j.xkme.2023.100705_bib50","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","article-title":"Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"35","author":"Gori","year":"2014","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.xkme.2023.100705_bib51","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.xkme.2023.100705_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","article-title":"Diuretic resistance in heart failure","volume":"16","author":"Gupta","year":"2019","journal-title":"Curr Heart Fail Rep"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib53","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ekir.2022.01.1067","article-title":"Prediction of incident heart failure in CKD: the CRIC study","volume":"7","author":"Zelnick","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.xkme.2023.100705_bib54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.xkme.2023.100705_bib55","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11739-019-02028-0","article-title":"Is echocardiography mandatory for patients with chronic kidney disease?","volume":"14","author":"Nardi","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"7","key":"10.1016\/j.xkme.2023.100705_bib56","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","article-title":"Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease","volume":"45","author":"Wali","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.xkme.2023.100705_bib57","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.acvd.2018.04.007","article-title":"Heart failure with preserved ejection fraction: A systemic disease linked to multiple comorbidities, targeting new therapeutic options","volume":"111","author":"Juilliere","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"issue":"19","key":"10.1016\/j.xkme.2023.100705_bib58","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ejhf.29","article-title":"Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved","volume":"16","author":"Rogers","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.xkme.2023.100705_bib60","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.xkme.2023.100705_bib61","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"9851","key":"10.1016\/j.xkme.2023.100705_bib62","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/14656566.2017.1288717","article-title":"Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine","volume":"18","author":"Polsinelli","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.xkme.2023.100705_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2215\/CJN.09380822","article-title":"Kidney-protective effects of SGLT2 inhibitors","volume":"18","author":"Palmer","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2023.100705_bib65","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"issue":"15","key":"10.1016\/j.xkme.2023.100705_bib66","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.xkme.2023.100705_bib67","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.xkme.2023.100705_bib68","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.xkme.2023.100705_bib69","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100705_bib70","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10741-020-09936-w","article-title":"Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic function in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis","volume":"26","author":"Ida","year":"2021","journal-title":"Heart Fail Rev"},{"issue":"5","key":"10.1016\/j.xkme.2023.100705_bib71","first-page":"965","article-title":"Nephroprotective effects of GLP-1 receptor agonists: where do we stand?","volume":"33","author":"Mosterd","year":"2020","journal-title":"J\u00a0Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10741-021-10106-9","article-title":"New antidiabetic therapy and HFpEF: light at the end of tunnel?","volume":"27","author":"Tadic","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.xkme.2023.100705_bib73","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.xkme.2023.100705_bib74","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.xkme.2023.100705_bib75","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.xkme.2023.100705_bib77","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.xkme.2023.100705_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022930","article-title":"Pragmatic weight management program for patients with obesity and heart failure with preserved ejection fraction","volume":"10","author":"El Hajj","year":"2021","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.xkme.2023.100705_bib79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.xkme.2023.100705_bib80","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10741-019-09774-5","article-title":"Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials","volume":"24","author":"Fukuta","year":"2019","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.xkme.2023.100705_bib81","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.121.053766","article-title":"Incorporating SGLT2i and GLP-1RA for cardiovascular and kidney disease risk reduction: call for action to the cardiology community","volume":"144","author":"Nelson","year":"2021","journal-title":"Circulation"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523001231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523001231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:25:55Z","timestamp":1762910755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059523001231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2590059523001231"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100705","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100705"}}